A Study of Daratumumab in Patients With Newly Diagnosed Multiple Myeloma

NCT03290950 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: daratumumab
DRUG: carfilzomib
DRUG: lenalidomide
DRUG: dexamethasone
DRUG: dexamethasone

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]